Recent progress of nanomedicine in the treatment of Alzheimer’s disease
Frontiers in Cell and Developmental Biology · 29.06.2023 · 11
DOI: 10.3389/fcell.2023.1228679 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 29.06.2023. Verfasst von Liqiang Hu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Mental Health Center and West China-California Research Center for Predictive Intervention Medicine, West China Hospital, Sichuan University, Chengdu…. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 156 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease (AD) is the most common cause of memory disruption in elderly subjects, with the prevalence continuing to rise mainly because of the aging world population. Unfortunately, no efficient therapy is currently available for the AD treatment, due to low drug potency and several challenges to delivery, including low bioavailability and the impediments of the blood-brain barrier. Recently, nanomedicine has gained considerable attention among researchers all over the world and shown promising developments in AD treatment. A wide range of nano-carriers, such as polymer nanoparticles, liposomes, solid lipid nanoparticles, dendritic nanoparticles, biomimetic nanoparticles, magnetic nanoparticles, etc. , have been adapted to develop successful new treatment strategies. This review comprehensively summarizes the recent advances of different nanomedicine for their efficacy in pre-clinical studies. Finally, some insights and future research directions are proposed. This review can provide useful information to guide the future design and evaluation of nanomedicine in AD treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Mental Health Center and West China-California Research Center for Predictive Intervention Medicine, West China Hospital, Sichuan University, Chengdu, China.
- College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.
- Andrology Laboratory, West China Hospital, Sichuan University, Chengdu, China.
- National Chengdu Center for Safety Evaluation of Drugs, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China.
Zitieren
APA
Hu, L., Tao, Y., Jiang, Y., & Qin, F. (2023). Recent progress of nanomedicine in the treatment of Alzheimer’s disease. Frontiers in Cell and Developmental Biology, 11. https://doi.org/10.3389/fcell.2023.1228679
Vancouver
Hu L, Tao Y, Jiang Y, Qin F. Recent progress of nanomedicine in the treatment of Alzheimer’s disease. Frontiers in Cell and Developmental Biology. 2023;11. doi:10.3389/fcell.2023.1228679
BibTeX
@article{Hu2023,
author = {Hu, Liqiang and Tao, Yiran and Jiang, Yanjiao and Qin, Feng},
title = {Recent progress of nanomedicine in the treatment of Alzheimer’s disease},
journal = {Frontiers in Cell and Developmental Biology},
year = {2023},
volume = {11},
doi = {10.3389/fcell.2023.1228679}
}
EUVIMED